Reviewing InfuSystem (NYSE:INFU) & PetVivo (NASDAQ:PETV)

InfuSystem (NYSE:INFU) and PetVivo (NASDAQ:PETV) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, dividends, earnings, risk, analyst recommendations, profitability and valuation.

Profitability

This table compares InfuSystem and PetVivo’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
InfuSystem	1.12%	2.78%	1.41%
PetVivo	-902.82%	-4,813.07%	-281.78%

Earnings and Valuation

This table compares InfuSystem and PetVivo”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
InfuSystem	$141.05 million	1.25	$870,000.00	$0.26	33.35
PetVivo	$1.05 million	37.60	-$10.95 million	($0.40)	-2.90

InfuSystem has higher revenue and earnings than PetVivo. PetVivo is trading at a lower price-to-earnings ratio than InfuSystem, indicating that it is currently the more affordable of the two stocks.

Risk & Volatility

InfuSystem has a beta of 1.68, meaning that its stock price is 68% more volatile than the S&P 500. Comparatively, PetVivo has a beta of 1.14, meaning that its stock price is 14% more volatile than the S&P 500.

Insider and Institutional Ownership

71.1% of InfuSystem shares are held by institutional investors. Comparatively, 24.5% of PetVivo shares are held by institutional investors. 11.4% of InfuSystem shares are held by insiders. Comparatively, 10.8% of PetVivo shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Analyst Ratings

This is a breakdown of current ratings and price targets for InfuSystem and PetVivo, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
InfuSystem	0	1	2	2	3.20
PetVivo	0	0	0	0	0.00

InfuSystem presently has a consensus target price of $14.50, suggesting a potential upside of 67.24%. Given InfuSystem’s stronger consensus rating and higher possible upside, analysts plainly believe InfuSystem is more favorable than PetVivo.

Summary

InfuSystem beats PetVivo on 14 of the 15 factors compared between the two stocks.

About InfuSystem

InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other healthcare site settings comprising hospitals, home care and home infusion providers, skilled nursing and acute care facilities, pain centers, and others. In addition, it offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan.

About PetVivo

PetVivo Holdings, Inc., a biomedical device company, engages in the manufacturing, commercializing, and licensing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. The company's pipeline products also include therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. was founded in 2009 and is headquartered in Minneapolis, Minnesota.